YOU ARE HERE: LAT HomeCollectionsArteriosclerosis


Arterial Vascular Engineering wants to be close to your heart--literally. The Santa Rosa company makes products for use in coronary balloon angioplasty operations. Arterial Vascular also makes stents, which are wire mesh devices that hold open a blood vessel after an angioplasty or other minimally invasive treatment of arteriosclerosis. Angioplasty, cheaper and less intrusive than traditional heart surgery, has steadily grown in popularity.
April 12, 1997 | From a Times Staff Writer
With 38 of the 39 bodies claimed by relatives, the county medical examiner made official Friday what investigators had suspected from the beginning: Members of the Heaven's Gate cult died from the effects of alcohol, phenobarbital and asphyxiation. In his final report on the mass suicide, Dr. Brian Blackbourne also listed coronary arteriosclerosis as a possible contributory cause in the suicide of cult leader Marshall Herff Applewhite.
July 18, 1988 | RANDY HARVEY, Times Staff Writer
When Carl Lewis charged last year in an interview with the British Broadcasting Corp. that world-class athletes have died from the use of performance-enhancing drugs, such as anabolic steroids, skeptics told him to name one. He could have named Birgit Dressel. Dressel, a West German heptathlete, finished fourth in the European Championships and was ranked No. 6 in the world in 1986. On April 10, 1987, she died after three days of agonizing pain in a Mainz, West Germany, hospital. She was 26.
In the summer of 1984, Jim Fixx appeared very much in his prime. The author of the 1977 bestseller "The Complete Book of Running" had transformed himself from an overweight, chain-smoking young man into an exemplar of good health--and inspired millions to do the same. He was running 10 miles a day. He was playing tennis. He was 52, famous and very fit. And one Friday, while traveling in Vermont, he decided to go for a run.
May 2, 1986 | ROBERT HANLEY, Times Staff Writer
Trimedyne Inc. said Thursday that within 90 days it will begin marketing its laser catheter in the United Kingdom, Germany and Sweden for treatment of arteriosclerosis in leg arteries. The three countries are the first to approve the new Laserprobe-PLR device, which uses a tiny laser beam located at the end of a catheter to vaporize fatty deposits blocking leg arteries. At present, bypass surgery and amputation are the primary treatments available to treat the disease.
Exercising your blood vessel muscles may help to keep your arteries healthy as you grow older, a noted heart researcher says. A study indicates that vigorous training may retard medial arteriosclerosis, a stiffening of the arteries that comes with age, according to Edward G. Lakatta. Lakatta differentiates between this condition and atherosclerosis, the clogging of arteries by fatty deposits. Either can lead to high blood pressure, heart disease and stroke.
March 1, 2004 | Jane E. Allen, Times Staff Writer
People who have high levels of cholesterol may be able to drink their way to a healthier heart using sterol-fortified orange juice. Plant sterols are thought to limit cholesterol absorption in the intestines, thereby reducing the amount that could clog arteries. They were put in fatty foods such as margarine and salad dressings because scientists thought the fats would help the sterols be better absorbed.
August 3, 1988 | ROD McCULLOM, Times Staff Writer
Booming sales of Trimedyne's medical laser catheters boosted the Santa Ana company's earnings to a record $1.5 million for the third quarter ending June 30. Profits increased sixfold from $203,000 a year earlier. Third-quarter sales were $8.3 million, more than double last year's $3.8 million. "(The results) surprised a few of us," said Dana Nickell, the firm's vice president of finance and chief financial officer. "We're growing at a tremendous rate."
May 10, 1988 | JOHN CHARLES TIGHE, Times Staff Writer
Trimedyne, the Santa Ana laser catheter maker, Monday reported record earnings of $1.2 million for the quarter ended March 31, compared to a net loss of $117,000 for the year-earlier period. Revenues for the company's fiscal 1988 second quarter increased 206% to $7 million, from $2.3 million. "I expected them to do well, but not that well," said Frank Ingersoll, an analyst at Knibb Securities in San Antonio, Tex. "They are doing some phenomenal things."
April 5, 1989 | JOHN CHARLES TIGHE, Times Staff Writer
Trimedyne Inc., a rapidly growing maker of laser catheters in Santa Ana, said Tuesday that it expects second quarter net earnings to be lower than the $769,000 earned in the same period a year ago. The company attributed the expected decline to the cost of growth. During the quarter, the company increased spending for staff, manufacturing, research and development, and clinical testing programs.
Los Angeles Times Articles